POLX.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 mai 2024 @ 15:51):

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom...

Stats
Dagens volum	205 054
Gjennomsnittsvolum	906 856
Markedsverdi	7.89M
EPS	£0 ( 2023-09-14 )
Neste inntjeningsdato	( £0 ) 2024-05-23
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.730
ATR14	£0.0350 (0.96%)

Polarean Imaging PLC Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Polarean Imaging PLC Økonomi

Annual	2022
Omsetning:	£1.03M
Bruttogevinst:	£348 276 (33.71 %)
EPS:	£-0.0667

FY	2022
Omsetning:	£1.03M
Bruttogevinst:	£348 276 (33.71 %)
EPS:	£-0.0667

FY	2021
Omsetning:	£1.19M
Bruttogevinst:	£508 025 (42.86 %)
EPS:	£-0.0710

FY	2020
Omsetning:	£1.06M
Bruttogevinst:	£710 467 (67.23 %)
EPS:	£-0.0610

Financial Reports:

No articles found.

Polarean Imaging PLC

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.